Afuco™ Anti-Human PILRA ADCC Therapeutic Antibody, ADCC Enhanced
Anti-PILRA ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibody is against FDF03 which is immunoregulatory receptor on myeloid cell, also known as Paired Immunoglobulin-Like type 2 Receptor (PILR). And it is used for the treatment of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-716CL |
| Pricing | Inquiry |
| Host | Human |
| Target | PILRA |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |